The accuracy of fine needle aspiration biopsy to diagnose breast neoplasm

https://doi.org/10.19106/JMedSci005103201907

Hifdza Faza Felisha(1), Hanggoro Tri Rinonce(2*), Sumadi Lukman Anwar(3), Ery Kus Dwianingsih(4)

(1) School of Medicine,Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta
(2) Department of Anatomical Pathology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta
(3) Department of Surgery, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta
(4) Department of Anatomical Pathology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta
(*) Corresponding Author

Abstract


Breast lump is a very common complaint among women, especially during the reproductive year. Fine needle aspiration biopsy (FNAB) is a less invasive procedure. It is usually performed as an initial diagnosis prior to the operative procedure. The accuracy of the FNAB in Indonesia needs to be elaborated. The study aimed to evaluate the sensitivity and specificity of FNAB in diagnosing breast neoplasm. This is a retrospective study with cross sectional design, involving 145 patients with breast lump who underwent FNAB and histopathology examination in Dr. Sardjito General Hospital, Yogyakarta, from 2012 to 2014. Data analysis showed that female to male ratio was 23. 2:1 commonly occurred at 41-50 years old. Forty-one cases (28.28%) diagnosed as a benign lesion with fibrocystic changes as the most frequentcase (11.19%). The malignant case was 104 cases (71.72%) with ductal carcinoma as the highest case (51.49%). FNAB achieved a sensitivity of 85.58%, a specificity of 100% and a total accuracy of 89.66% in determining the benign or malignant breast lump. The accuracy, sensitivity and specificity of FNAB in diagnosing ductal carcinoma were 83.58%, 85.51% and 81.54%, respectively. The accuracy, sensitivity and specificity of FNAB to diagnose fibrocystic changes lesion were 85.82%, 26.67% and 93.28%, respectively. FNAB can be used as an alternative diagnostic tool to diagnose breast neoplasm. It provides rapid, cheaper, effective, valuable, and less invasive procedure in diagnosis of breast lump.

 


Keywords


FNAB; breast lump; sensitivity; specificity; diagnosis

Full Text:

PDF


References

  1. Saunders C. Breast lump and lesions. VMC 2014.
  2. Wechter DG, Zieve D. ADAM. Inc. Breast Lump. University of Maryland Medical Center, 2013.
  3. Kumar V, Abbas AK, Aster JC. Robbins and Cotran pathologic basis of disease 9th ed. Canada: Elsevier Saunders; 2015.
  4. John Hopkins Medicine. What is Breast Biopsy? John Hopkins Medicine, 2015.
  5. International Agency for Research on Cancer. Latest world cancer statistics global cancer burden rises to 14.1 million new cases in 2012: marked Increase in Breast Cancers must be addressed. Lyon: WHO, 2013.
  6. Infodatin. Stop kanker. Jakarta: Kementerian Kesehatan RI. 2015.
  7. American Cancer Society. Breast Cancer. American Cancer Society Inc. 2015.
  8. Borecky N. Breast fine needle aspiration biopsy. The Royal Australian and New Zealand College of Radiologist; 2009.
  9. Amedee RG & Dhurandhar NR. Fine needle aspiration biopsy. Laryngoscope 2001; 111(9):1551-7. https://doi.org/10.1097/00005537-200109000-00011
  10. Millis RR. Needle biopsy of the breast. Monogr Pathol 1984; 1984(25):186-203. https://doi.org/10.1007/978-94-009-6589-8_7
  11. Anonim. Breast fine needle aspiration cytology and core biopsy: a Guide for Practice.Camperdown (NSW). USA: National Breast Cancer Centre; 2004.
  12. Anonim. How is breast cancer diagnosed? USA: Center for Disease Control and Prevention; 2014.
  13. Anonim. Biopsy. USA: National Breast Cancer Foundation Inc.; 2012.
  14. Calhoun KE, Anderson BO. Needle biopsy for breast cancer diagnosis: a quality metric for breast surgical practice. J Clin Oncol 2014; 32(21):2191-2. https://doi.org/10.1200/JCO.2014.55.6324
  15. American Academy of Otolaryngology. Fine needle aspiration biopsy. American Acaddemy of Otolaryngology- Head and Neck Surgery; 2015.
  16. Bukhari MH, Arshad M, Jamal S, Niazi S, Bashir S, Bakhshi IM, et al. Use of fine-needle aspiration in the evaluation of breast lumps. Pathol Res Int 2011; 2011:689521. https://doi.org/10.4061/2011/689521
  17. Akobeng AK. Understanding diagnostic test 1: sensitivity, specificity and predictive values. Acta Paediatr 2007; 96(3):338-41. https://doi.org/10.1111/j.1651-2227.2006.00180.x
  18. Pradana JA, Sukarya WS. Nilai diagnostik pemeriksaan biopsi aspirasi jarum halus (BAJAH) dalam mendiagnosis kanker payudara yang dikonfirmasi dengan hasil pemeriksaan histopatologi (Suatu uji diagnostik di RSUD. Dr. Soedarso Pontianak Periode 2006-2010 [Progam Kreativitas Mahasiswa (PKM)]. Bandung: Universitas Islam Bandung; 2011.
  19. Department of Statistics Eberly College of Science. Medical diagnostic testing. Pennsylvania: The Pennsylvania State University, 2015.
  20. Parikh R, Mathai A, Parikh S, Sekhar GC, Thomas R. Understanding and using sensitivity, specificity and predictive value. Indian J Opthalmol 2008; 56(1):45-50. https://doi.org/10.4103/0301-4738.37595
  21. Sastroasmoro S, Ismael S. Dasar-dasar metodologi penelitian klinis. 4th edition. Jakarta: Sagung Seto; 2011.
  22. Siswanto, Susila, Suyanto. Metodologi penelitian kesehatan dan kedokteran. 1st ed. Yogyakarta: Bursa Ilmu; 2014.
  23. Mendoza P, Lacambra M, Tan PH, Tse GM. Fine needle aspiration cytology of the breast: the nonmalignant categories. Pathol Res Int 2011; 2011:547580. https://doi.org/10.4061/2011/547580
  24. Sari K, Sulastri H, Maulani H, Rahadiyanto KY. Keakuratan diagnosis pemeriksaan sitologi aspirasi jarum halus pada tumor payudara di RSUP.Dr. Mohammad Hoesin Palembang. Majalah Patologi 2011; 20(2):1-5.



DOI: https://doi.org/10.19106/JMedSci005103201907

Article Metrics

Abstract views : 2321 | views : 3187


Bookmark and Share


Copyright (c) 2017 Hifdza Faza Felisha, Hanggoro Tri Rinonce, Sumadi Lukman Anwar, Ery Kus Dwianingsih

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.